CoChat

The Postbiotic Activity of Lactobacillus paracasei 28.4 Against Candida auris

Open access
Rossoni, Rodnei Dennis, de Barros, Patrícia Pimentel, Mendonça, Iatã do Carmo, Medina, Rebeca Previate, Silva, Dulce Helena Siqueira, Fuchs, Beth Burgwyn, Junqueira, Juliana Campos, Mylonakis, Eleftherios · 2020 · Frontiers in Cellular and Infection Microbiology
Cited by 102

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Candida auris has emerged as a medically important pathogen with considerable resistance to antifungal agents. The ability to produce biofilms is an important pathogenicity feature of this species that aids escape of host immune responses and antimicrobial agents. The objective of this study was to verify antifungal action using in vitro and in vivo models of the Lactobacillus paracasei 28.4 probiotic cells and postbiotic activity of crude extract (LPCE) and fraction 1 (LPF1), derived from L. paracasei 28.4 supernatant. Both live cells and cells free supernatant of L. paracasei 28.4 inhibited C. auris suggesting probiotic and postbiotic effects. The minimum inhibitory concentration (MIC) for LPCE was 15 mg/mL and ranges from 3.75 to 7.5 mg/mL for LPF1. Killing kinetics determined that after 24 h treatment with LPCE or LPF1 there was a complete reduction of viable C. auris cells compared to fluconazole, which decreased the initial inoculum by 1-logCFU during the same time period. LPCE and LPF1 significantly reduced the biomass (p=0.0001) and the metabolic activity (p=0.0001) of C. auris biofilm. There was also a total reduction (~108 CFU/mL) in viability of persister C. auris cells after treatment with postbiotic elements (p<0.0001). In an in vivo study, injection of LPCE and LPF1 into G. mellonella larvae infected with C. auris prolonged survival of these insects compared to a control group (p<0.05) and elicited immune responses by increasing the number of circulating hemocytes and gene expression of antimicrobial peptide galiomicin. We concluded that the L. paracasei 28.4 cells and postbiotic elements (LPCE and LPF1) have antifungal activity against planktonic cells, biofilms, and persister cells of C. auris. Postbiotic supplementation derived from L. paracasei 28.4 protected G. mellonella infected with C. auris and enhanced its immune status indicating a dual function in modulating a host immune response.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fcimb.2020.00397

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Research works printed but not linked: 54

  1. Bergin, 2003, Fluctuations in haemocyte density and microbial load may be used as indicators of fungal pathogenicity in larvae of Galleria mellonella, Microbes Infect, 5, 1389, 10.1016/j.micinf.2003.09.019 · DOI
  2. Bidaud, 2018, Candida auris: an emerging drug resistant yeast—a mini-review, J. Mycol. Med, 28, 568, 10.1016/j.mycmed.2018.06.007 · DOI · Paper page
  3. Bigger, 1944, Treatment of Staphylococcal infections with penicillin by intermittent sterilisation, Lancet, 244, 497, 10.1016/S0140-6736(00)74210-3 · DOI · Paper page
  4. 2016, Global Emergence of Invasive Infections Caused by the Multidrug-Resistant Yeast Candida auris
  5. Cernakova, 2019, Novel therapies for biofilm-based Candida spp. infections, Adv. Exp. Med. Biol, 1214, 93, 10.1007/5584_2019_400 · DOI
  6. Chakrabarti, 2020, Multidrug-resistant Candida auris: an epidemiological review, Expert Rev. Anti Infect. Ther, 18, 551, 10.1080/14787210.2020.1750368 · DOI · Paper page
  7. Cicenia, 2014, Postbiotic activities of lactobacilli-derived factors, J. Clin. Gastroenterol, 48, S18, 10.1097/MCG.0000000000000231 · DOI · Paper page
  8. Compare, 2017, Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome, BMC Gastroenterol, 17, 53, 10.1186/s12876-017-0605-x · DOI · Paper page
  9. Davies, 2003, Understanding biofilm resistance to antibacterial agents, Nat. Rev. Drug Discov, 2, 114, 10.1038/nrd1008 · DOI · Paper page
  10. de Barros, 2018, Lactobacillus paracasei 28.4 reduces in vitro hyphae formation of Candida albicans and prevents the filamentation in an experimental model of Caenorhabditis elegans, Microb. Pathog, 117, 80, 10.1016/j.micpath.2018.02.019 · DOI
  11. Dunand, 2019, Postbiotics produced at laboratory and industrial level as potential functional food ingredients with the capacity to protect mice against Salmonella infection, J. Appl. Microbiol, 127, 219, 10.1111/jam.14276 · DOI
  12. Gao, 2019, A novel postbiotic from Lactobacillus rhamnosus GG with a beneficial effect on intestinal barrier function, Front. Microbiol, 10, 477, 10.3389/fmicb.2019.00477 · DOI · Paper page
  13. Geraldo, 2019, Heat-killed Lactobacillus reuteri and cell-free culture supernatant have similar effects to viable probiotics during interaction with Porphyromonas gingivalis, J. Periodontal. Res., 55, 215, 10.1111/jre.12704 · DOI · Paper page
  14. Gillum, 1984, Isolation of the Candida albicans gene for orotidine-5'-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations, Mol. Gen. Genet, 198, 179, 10.1007/BF00328721 · DOI · Paper page
  15. Hu, 2017, Probiotics prevent Candida colonization and invasive fungal sepsis in preterm neonates: a systematic review and meta-analysis of randomized controlled trials, Pediatr. Neonatol, 58, 103, 10.1016/j.pedneo.2016.06.001 · DOI · Paper page
  16. Janczarek, 2016, The role of probiotics in prevention of oral diseases, Postepy Hig. Med. Dosw., 70, 850, 10.5604/17322693.1214381 · DOI
  17. Jin, 2004, Biofilm formation of Candida albicans is variably affected by saliva and dietary sugars, Arch. Oral Biol, 49, 789, 10.1016/j.archoralbio.2004.04.011 · DOI · Paper page
  18. Johnson, 2019, Administration of a postbiotic causes immunomodulatory responses in broiler gut and reduces disease pathogenesis following challenge, Microorganisms, 7, 268, 10.3390/microorganisms7080268 · DOI · Paper page
  19. Kavanagh, 2004, Exploiting the potential of insects for in vivo pathogenicity testing of microbial pathogens, FEMS Microbiol. Rev, 28, 101, 10.1016/j.femsre.2003.09.002 · DOI · Paper page
  20. Mailander-Sanchez, 2012, Potential role of probiotic bacteria in the treatment and prevention of localised candidosis, Mycoses, 55, 17, 10.1111/j.1439-0507.2010.01967.x · DOI
  21. Martins, 2014, Candidiasis: predisposing factors, prevention, diagnosis and alternative treatment, Mycopathologia, 177, 223, 10.1007/s11046-014-9749-1 · DOI · Paper page
  22. Medina, 2019, Botryane terpenoids produced by Nemania bipapillata, an endophytic fungus isolated from red alga Asparagopsis taxiformis—Falkenbergia stage, Sci. Rep, 9, 12318, 10.1038/s41598-019-48655-7 · DOI
  23. Mosca, 2019, Can postbiotics represent a new strategy for NEC?, Adv. Exp. Med. Biol, 1125, 37, 10.1007/5584_2018_314 · DOI
  24. Mowlds, 2010, Dose-dependent cellular and humoral responses in Galleria mellonella larvae following beta-glucan inoculation, Microbes Infect, 12, 146, 10.1016/j.micinf.2009.11.004 · DOI
  25. Mylonakis, 2005, Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis, Infect. Immun, 73, 3842, 10.1128/IAI.73.7.3842-3850.2005 · DOI · Paper page
  26. 2002, “Reference method for broth dilution antifungal susceptibility testing of yeasts,”
  27. Pathirana, 2018, Fluconazole-resistant Candida auris is susceptible to salivary histatin 5 killing and to intrinsic host defenses, Antimicrob. Agents Chemother, 62, e01872, 10.1128/AAC.01872-17 · DOI
  28. Peeters, 2008, Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates, J. Microbiol. Methods, 72, 157, 10.1016/j.mimet.2007.11.010 · DOI · Paper page
  29. Peleg, 2008, Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans, Proc. Natl. Acad. Sci. U. S. A., 105, 14585, 10.1073/pnas.0805048105 · DOI · Paper page
  30. Pereira, 2018, Recent advances in the use of galleria mellonella model to study immune responses against human pathogens, J. Fungi., 4, 128, 10.3390/jof4040128 · DOI · Paper page
  31. Ribeiro, 2017, Lactobacillus rhamnosus inhibits Candida albicans virulence factors in vitro and modulates immune system in Galleria mellonella, J. Appl. Microbiol, 122, 201, 10.1111/jam.13324 · DOI · Paper page
  32. Ribeiro, 2020, Development of probiotic formulations for oral candidiasis prevention: Gellan gum as a carrier to deliver Lactobacillus paracasei 28.4, Antimicrob. Agents Chemother, 6, e02323, 10.1128/AAC.02323-19 · DOI
  33. Riccardi, 2019, Definition of opportunistic infections in immunocompromised children on the basis of etiologies and clinical features: a summary for practical purposes, Curr. Pediatr. Rev, 15, 197, 10.2174/1573396315666190617151745 · DOI
  34. Rodrigues, 2019, Promising alternative therapeutics for oral candidiasis, Curr. Med. Chem, 26, 2515, 10.2174/0929867325666180601102333 · DOI
  35. Rodrigues, 2019, Candida spp./bacteria mixed biofilms, J. Fungi., 6, 5, 10.3390/jof6010005 · DOI · Paper page
  36. Rodrigues, 2016, Novel strategies to fight Candida species infection, Crit. Rev. Microbiol, 42, 594, 10.3109/1040841X.2014.974500 · DOI
  37. Rossato, 2018, Candida auris: what have we learned about its mechanisms of pathogenicity?, Front. Microbiol, 9, 3081, 10.3389/fmicb.2018.03081 · DOI · Paper page
  38. Rossoni, 2018, Antifungal activity of clinical Lactobacillus strains against Candida albicans biofilms: identification of potential probiotic candidates to prevent oral candidiasis, Biofouling, 34, 212, 10.1080/08927014.2018.1425402 · DOI · Paper page
  39. Rossoni, 2019, C. albicans infection. Biofouling, 35, 997, 10.1080/08927014.2019.1686485 · DOI
  40. Rossoni, 2017, Lactobacillus paracasei modulates the immune system of Galleria mellonella and protects against Candida albicans infection, PLoS ONE, 12, e0173332, 10.1371/journal.pone.0173332 · DOI
  41. Santos, 2019, Lactobacillus species increase the survival of Galleria mellonella infected with Candida albicans and non-albicans Candida clinical isolates, Med. Mycol, 57, 391, 10.1093/mmy/myy032 · DOI
  42. Scalfaro, 2017, Galleria mellonella as an in vivo model for assessing the protective activity of probiotics against gastrointestinal bacterial pathogens, FEMS Microbiol. Lett, 364, 1, 10.1093/femsle/fnx064 · DOI
  43. Sekyere, 2018, Emerging mechanisms of antimicrobial resistance in bacteria and fungi: advances in the era of genomics, Future Microbiol, 13, 241, 10.2217/fmb-2017-0172 · DOI
  44. Serra, 2015, Vertical stratification of matrix production is essential for physical integrity and architecture of macrocolony biofilms of Escherichia coli, Environ. Microbiol, 17, 5073, 10.1111/1462-2920.12991 · DOI
  45. Shai, 2002, Mode of action of membrane active antimicrobial peptides, Biopolymers, 66, 236, 10.1002/bip.10260 · DOI · Paper page
  46. Sheehan, 2018, Analysis of the early cellular and humoral responses of Galleria mellonella larvae to infection by Candida albicans, Virulence, 9, 163, 10.1080/21505594.2017.1370174 · DOI
  47. Tharmalingam, 2019, The anti-virulence efficacy of 4-(1,3-dimethyl-2,3-dihydro-1h-benzimidazol-2-yl)phenol against methicillin-resistant Staphylococcus aureus, Front. Microbiol, 10, 1557, 10.3389/fmicb.2019.01557 · doi:10.3389/fmicb.2019.01557
  48. Tsai, 2016, Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing, Virulence, 7, 214, 10.1080/21505594.2015.1135289 · DOI · Paper page
  49. Tsilingiri, 2012, Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model, Gut, 61, 1007, 10.1136/gutjnl-2011-300971 · DOI · Paper page
  50. Tsilingiri, 2013, Postbiotics: what else?, Benef. Microbes, 4, 101, 10.3920/BM2012.0046 · DOI · Paper page
  51. Vicariotto, 2012, Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study, J. Clin. Gastroenterol, 46, S73, 10.1097/MCG.0b013e3182684d71 · DOI · Paper page
  52. Vilela, 2015, Lactobacillus acidophilus ATCC 4356 inhibits biofilm formation by C. albicans and attenuates the experimental candidiasis in Galleria mellonella, Virulence, 6, 29, 10.4161/21505594.2014.981486 · DOI · Paper page
  53. Wegh, 2019, Postbiotics and their potential applications in early life nutrition and beyond, Int. J. Mol. Sci, 20, 4673, 10.3390/ijms20194673 · DOI · Paper page
  54. Wojda, 2017, Immunity of the greater wax moth Galleria mellonella, Insect. Sci, 24, 342, 10.1111/1744-7917.12325 · doi:10.1111/1744-7917.12325

Cited by

See all 102

Metadata

Authors
Rossoni, R. D., de Barros, P. P., Mendonça, I. D. C., Medina, R. P., Silva, D. H. S., Fuchs, B. B., Junqueira, J. C., & Mylonakis, E.
Venue
Frontiers in Cellular and Infection Microbiology
Published
2020-08-04
Volume
10
Pages
397-397
ISSN
2235-2988 (ISSN-L)
OpenAlex
W3041615144
Cited by
102
References
19
FWCI
5.51
Type
journal article
Language
en
Open access
gold
Funders
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (2017/19219-3, 2018/21239-5)
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (306330/2018-0)
  • National Institutes of Health (P20 GM121344)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Postbiotic Activity of Lactobacillus paracasei 28.4 Against Candida auris. https://app.cochat.ai/papers/10.3389/fcimb.2020.00397
The paper
Rossoni, R. D., de Barros, P. P., Mendonça, I. D. C., Medina, R. P., Silva, D. H. S., Fuchs, B. B., Junqueira, J. C., & Mylonakis, E. (2020). The Postbiotic Activity of Lactobacillus paracasei 28.4 Against Candida auris. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2020.00397

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.